Distance- Based Physical Activity Intervention for Rural Lung Cancer Survivors.

Authors
Category Primary study
Registry of TrialsANZCTR
Year 2012
INTERVENTION: Participants randomized to the intervention arm will receive print‐based materials and telephone follow‐up designed to increase physical activity participation for 12‐weeks. Telephone follow‐up and print materials mailout will occur weekly for one month, with fortnightly contact for the last two months. All physical activity will be home‐based. Constructs from the Theory of Planned Behavior informed the intervention materials. CONDITION: Lung Cancer PRIMARY OUTCOME: Feasibility of the intervention as measured by reach (participants enrolled/participants screened and eligible), retention (participants completing post intervention assessment/participants enrolled), adherence to telephone support (number of telephone sessions completed/total number possible), and adverse events (number of adverse events reported during telephone support, and/or in questionnaire). SECONDARY OUTCOME: Anxiety and Depression: The Brief Symptom Inventory‐18 Fatigue using the FACIT‐Fatigue scale Health‐related quality of life, measured using: The Medical Outcomes Study Short‐Form 36 and the Functional Assessment of Cancer Therapy ‐ Lung Cancer Patient rated function: Late Life Function Index Physical Activity Motivation: Theory of Planned Behaviour constructs (affective and instrumental attitude, injunctive and descriptive norm, self‐efficacy, perceived behavioural control, intention, and planning) will be assessed using a standard TPB Questionnaire. Physical Activity assessed by the Godin Leisure‐Time Questionnaire, and a domain specific sedentary behavior questionnaire, and triaxial accelerometry Ratings of burden and acceptability will be assessed by questionnaire specifically designed for this study. Shortness of breath measure by the cancer dyspnea scale and the MRC Dyspnea scale Sleep quality, measured by the Pittsburgh Sleep Quality Index INCLUSION CRITERIA: Confirmed stage I‐IIIB non‐small cell lung cancer or limited stage small cell lung cancer and not currently on treatment for cancer.
Epistemonikos ID: 5ed5afe707b30e70d870f606ae447ec5fee9dbb2
First added on: Aug 25, 2024